课题基金 / 基金详情

CLINICAL TRIAL: TRIAL IN ANTIRETROVIRAL NAIVE HIV SUBJECTS

CLINICAL TRIAL: TRIAL IN ANTIRETROVIRAL NAIVE HIV SUBJECTS
临床试验：在未接受抗逆转录病毒治疗的艾滋病毒感染者中进行试验
批准号：
7724927
负责人：
CONSTANCE ANN BENSON
金额：
$0.25万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
项目状态：
已结题
起止时间：
2007-12-01 至 2008-11-30
来源：
https://reporter.nih.gov/project-details/7724927
关键词：
Anti-Retroviral AgentsClinical TrialsComputer Retrieval of Information on Scientific Projects DatabaseFundingGrantInstitutionPharmaceutical PreparationsResearchResearch PersonnelResourcesSafetySourceUnited States National Institutes of Health

项目摘要

项目成果

CONSTANCE ANN BENSON的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 研究药物的有效性、安全性和耐受性。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To study efficacy, safety and tolerability of the drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pooled and conventional nucleic acid testing strategies for SARS-CoV-2 to screen direct care research staff and protect HIV patients
A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention
A Novel Wireless Ingestible Sensor System for Measurement of medication Adherence in HIV Treatment and Prevention
A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention
海外基金